Arteriopathies are the leading cause of childhood stroke but mechanisms are poorly understood. Fibromuscular dysplasias are noninflammatory arteriopathies classically described in adults with a cerebral-renal distribution and distinct 'string-of-beads' angiographic appearance. Diagnostic characteristics of paediatric fibromuscular dysplasia are uncharacterized. We aimed to compare pathologically proven versus clinically suspected paediatric fibromuscular dysplasia stroke cases to elucidate diagnostic features. Children in the Canadian Paediatric Ischaemic Stroke Registry, Calgary Paediatric Stroke Program, and published literature were screened for stroke associated with fibromuscular dysplasias or renal arteriopathy. Comparison variables included pathological classification, presentations, stroke types, imaging/angiography, treatments, and outcomes. We report 81 cases (15 new, 66 from the literature). For pathologically proven fibromuscular dysplasia (n = 27), intimal fibroplasia predominated (89%) and none had typical adult medial fibroplasia. Ischaemic strokes predominated (37% haemorrhagic) and were often multifocal (40%). Children often presented early (33% 512 months). Angiography demonstrated focal, stenotic arteriopathy (78%) rather than 'string-ofbeads'. Renal arteriopathy (63%) with hypertension (92%) was common, with systemic arteriopathy in 72%, and moyamoya in 35%. Anti-inflammatory (29%) and anti-thrombotic (27%) therapies were inconsistently applied. Outcomes (mean 43 months) were poor in 63%, with stroke recurrence in 36%. Clinically suspected fibromuscular dysplasias (n = 31) were usually older, normotensive with string-of-beads angiography and good outcome. We conclude that fibromuscular dysplasia causes childhood stroke with distinctive clinic-radiological features including hypertension and systemic arteriopathy. Intimal fibroplasia predominates while 'string of beads' angiography is rare. Accurate clinical diagnosis is currently challenging.
Introduction
Stroke causes lifelong neurological morbidity in children. Arteriopathies are the leading cause of both occurrence and recurrence but mechanisms are poorly understood (Fullerton et al., 2007; Amlie-Lefond et al., 2009) The result is that treatment and prevention strategies are limited with poor outcomes in most survivors (deVeber et al., 2000) . Whereas pathological confirmation is lacking in most cases, the recognition and classification of childhood cerebral arteriopathies has recently improved (Bernard et al., 2012) . Differential diagnosis includes well-recognized entities such as dissection, moyamoya and clinicoradiographic syndromes of possible parainfectious or inflammatory mechanisms (e.g. focal or transient cerebral arteriopathy, primary angitiis or post-varicella angiopathy). Additional forms of childhood cerebral arteriopathy are suspected but undefined.
Fibromuscular dysplasias are a group of idiopathic, non-inflammatory arteriopathies with distinct pathological and angiographic findings (Slovut and Olin, 2004) The most commonly described form of fibromuscular dysplasia is medial fibroplasia/dysplasia, typically affecting young adult females with renal and cerebral vessel involvement, distinct 'string of beads' angiography, refractory hypertension, and stroke (Slovut and Olin, 2004; Touze et al., 2010) . Exceptions to this classical syndrome are recognized including multiple pathological subtypes of fibromuscular dysplasia, most of which lack such distinct, recognizable angiography. Isolated paediatric cases of possible fibromuscular dysplasia have been reported over decades, though most lack pathological confirmation. Further complicating matters is the now well recognized finding of string-of-beads arteriopathy in other defined causes of childhood stroke (Braun et al., 2009; Ganesan et al., 2011) .
The association between renal arteriopathy and stroke in adults is relatively well established with most cases related to atherosclerosis and a small proportion attributable to fibromuscular dysplasia (Zeller, 2005) . The relationship between renal arteriopathy and childhood stroke has not been evaluated. However, descriptions are present, particularly in moyamoya syndrome, a relatively common arteriopathic cause of stroke in children (Scott and Smith, 2009) .
We present an analysis combining a systematically collected series of children with an exhaustive literature review to better define the relationship between fibromuscular dysplasia, renal arteriopathy and childhood stroke. We hypothesized that pathologically-proven fibromuscular dysplasia associated with childhood stroke is a unique syndrome, different from adult fibromuscular dysplasia and lacking string-of-beads angiography.
Materials and methods

Patient populations
Cases were identified from three different sources according to predefined criteria.
The Canadian Paediatric Ischaemic Stroke Registry Cases (CPISR) is a national population-based stroke registry established in January 1992 that recruited patients until December 2001 (deVeber et al., 2001 . All ischaemic stroke cases (birth to 18 years) were systematically identified across all 16 paediatric tertiary care institutions in Canada through coinvestigator clinical identification and ICD-9 and ICD-10 code searching. Comprehensive data collection was performed by trained study personnel and entered in a centralized database. For this study, the CPISR database was screened for the following terms: fibromuscular dysplasia, fibromuscular hyperplasia, renal artery stenosis and hypertension. Potential cases were then reviewed for inclusion by the principal investigator (A.K.) with discussion with site co-investigators as needed. Criteria for inclusion were the following: (i) arterial ischaemic stroke with pathological diagnosis of fibromuscular dysplasia; (ii) arterial ischaemic stroke with angiographic or other clinical diagnosis of fibromuscular dysplasia by the site investigator; or (iii) arterial ischaemic stroke with associated renal arteriopathy. Cerebral sinovenous thrombosis and haemorrhagic strokes were excluded (latter is included in next two sources). For all confirmed cases, data points were then extracted under the CPISR headings of patient demographics, clinical presentation, diagnostic imaging, risk factor investigations, treatment, and neurological outcomes. When possible and with permission, copies of neuroimaging, angiography, and pathology were obtained from the original institutions and reviewed. All CPISR sites carried institutional research ethics board approval.
The Calgary Paediatric Stroke Program is a provincial, populationbased registry that enrolled patients between 2007 and 2010. All paediatric cerebrovascular disease cases identified in Southern Alberta were systematically identified and enrolled including childhood arterial ischaemic and haemorrhagic stroke. The Calgary Paediatric Stroke Program database was searched using the same key terms as above. Cerebral sinovenous thrombosis was excluded. Any potential case meeting the inclusion criteria above was selected for the current study and its data points for the same fields as above, as well as all imaging and pathology studies, were extracted for analysis. All methods were approved by the institutional research ethics board. All subjects from both registries provided informed consent.
For a systematic literature review, a Pubmed search was performed using the following terms: stroke, paediatric stroke, childhood stroke, child, arterial ischaemic stroke, haemorrhagic stroke, subarachnoid haemorrhage, intracranial haemorrhage, renal artery stenosis, fibromuscular dysplasia, fibromuscular hyperplasia and arteriopathy. The bibliographies of identified studies were also screened for any potential cases. Articles written in all languages were included, including articles in Spanish, Polish and Japanese. Health care professionals in our department fluent in each language were familiarized with the methods of the study and the data fields of interest. They were then asked to translate the articles in conjunction with an investigator (M.H.) to fill as many data fields as possible. Inclusion criteria for literature cases were: (i) stroke (ischaemic or haemorrhagic) or transient ischaemic attack; (ii) age (428 days-18 years) at neurological presentation; (iii) pathological, angiographic or other clinical diagnosis of fibromuscular dysplasia and/or renal arteriopathy; and (iv) sufficient provision of essential historical and investigational details (see below).
In the interest of creating the most uniform population with the greatest likelihood of having fibromuscular dysplasia, studies with a primary inclusion of moyamoya disease or syndrome were deliberately not included due to overlapping features with our population of interest (see 'Discussion' section). Individual cases meeting inclusion criteria with co-existent moyamoya were included. Clinical or angiographyonly diagnoses of fibromuscular dysplasia were specifically included for comparison to the pathologically proven cases. Details of imaging, angiography, and pathological findings were directly quoted.
Variables
A structured data capture form was developed to consistently score all variables of interest. These included patient demographics (age, gender, ethnicity) 
Pathological classification
Evidence-based pathological fibromuscular dysplasia classification was based on the system developed by Harrison and McCormick (1971) and Stanley et al. (1975) . Though simplifications to this system have been proposed, the original remains the accepted standard (Touze et al., 2010) In addition, previous correlations between this system and cerebral angiography findings were essential to our analysis. These original descriptions also date back to 1971, facilitating maximum overlap between classification terminology and our earliest literature cases. Accordingly, pathological classifications were as follows: medial fibroplasia/dysplasia, perimedial fibroplasia, medial hyperplasia, intimal fibroplasia or adventitial hyperplasia (AH). This classification is restricted to pathological changes restricted to defined arterial wall layers. Pathological findings not conforming to an established Harrison and McCormick grade but otherwise meeting fibromuscular dysplasia criteria were labelled as unclassifiable. Pathological classification of each case was based on best available information and performed by the study pathologist in a blinded fashion.
Angiographic classification
Angiographic descriptions of arteriopathy were characterized. Correlations between different pathologically proven fibromuscular dysplasia subtypes and angiography have been established. For example, string-of-beads has been associated with medial fibroplasia/dysplasia and perimedial fibroplasia, while tubular or focal stenosis has been correlated with medial hyperplasia, intimal fibroplasia or adventitial hyperplasia (Osborn and Anderson, 1977; Slovut and Olin, 2004) . In addition, preliminary review of the literature suggested that many cases of clinically suspected 'fibromuscular dysplasia' were based on such angiographic findings. Hence, a comparison of angiography findings between pathologically and clinically suspected cases was desired. When sufficient detail was available, angiographic patterns were dichotomized as either 'string of beads' (stated or areas of alternating stenosis and dilatation described) versus focal or segmental stenosis or occlusion.
Analysis
Cases from all sources with pathologically proven fibromuscular dysplasia constituted the primary population for analysis. A descriptive analysis of this population was performed. Following this, three predefined groups were compared: (i) pathologically proven fibromuscular dysplasia; (ii) clinically suspected fibromuscular dysplasia (based on angiography or other clinical indication only as interpreted by the reporting authors); and (iii) all remaining cases. This final category was intended as hypothesis generating only, defined to provide a comparative sample meeting our specific inclusion criteria who could not be classified as pathological or clinically suspected fibromuscular dysplasia. For categorical variables, Chi-square analysis with Benjamini correction for multiple comparisons was employed. For continuous variables, box-plots confirmed normal or near-normal distributions. This was followed by an ANOVA to determine if a difference existed between groups. When a difference across groups was confirmed, pair-wise comparisons were subsequently performed between the pathologically proven and clinically suspected fibromuscular dysplasia subgroups. Pair-wise comparisons employed Chi-square/Fisher's exact (categorical) or Tukey's honest difference tests (continuous variables).
Results
Populations
A total of 81 cases of childhood stroke associated with fibromuscular dysplasia and/or renal arteriopathy were included. Stroke types included arterial ischaemic stroke or transient ischaemic attack alone in 66 (81%), haemorrhagic stroke alone in 13 cases (16%), and both in two cases (2.5%).
Eleven new cases were identified from the CPISR. During the same time period, a total of 1169 cases with arterial ischaemic stroke were identified through the CPISR. This suggests an association of fibromuscular dysplasia or renal arteriopathy with 51% of childhood arterial ischaemic stroke cases. Recognizing limitations of diagnostic accuracy, the population-based nature of the CPISR would estimate the minimum incidence of childhood arterial ischaemic stroke associated with fibromuscular dysplasia or renal arteriopathy is $1:3 000 000 children per year. An additional four patients with arterial ischaemic stroke associated with renal arteriopathy and/or fibromuscular dysplasia were identified from the Calgary Paediatric Stroke Program database.
Sixty-six literature cases from a total of 125 potential articles were identified. Publication dates ranged from 1967 to 2009. Most were single case reports (92.4%) whereas the remainder were small case series (ranging from two to six patients). Fiftynine articles (47%) were excluded (Supplementary Table 1 ) for the following reasons: no confirmed stroke (30), age 418 years (12), no fibromuscular dysplasia or renal artery stenosis (7), insufficient data provided (6), or no actual cases reported (4). Nine articles were translated into English from languages including Spanish (3), Japanese (3), German (1) and Polish (1).
Pathologically proven fibromuscular dysplasia
Twenty-seven cases with stroke and pathologically proven fibromuscular dysplasia were identified and represent the primary population for analysis. A representative case is shown in Fig. 2 . Six (22.2%) were new and previously unreported cases whereas the remainder (77.8%) were extracted from the literature. Pathological confirmation methods included autopsy (45%), post-nephrectomy renal artery pathology (25%), other surgical resection (20%) or temporal arterial biopsy (10%). A wide time range of reported cases was noted with 40% published between 1967 and 1995. The details of the 27 pathologically proven patients with fibromuscular dysplasia are summarized in Table 1 .
Pathological classification of fibromuscular dysplasia was possible in 19 of 27 cases (70%). Despite being a rare form of adult fibromuscular dysplasia, the intimal fibroplasia subtype predominated, present in 17 (89%) cases. The medial hyperplasia subtype was described in two additional cases. No examples of the remaining classification subtypes were found (medial fibroplasia/dysplasia, perimedial fibroplasia, and adventitial hyperplasia). Overlapping features of various subtypes were described in the eight unclassifiable cases, all of which had extensive changes throughout multiple layers of the arterial wall.
No significant gender difference was observed across the three groups (59% male, P = 0.34). Median age at neurological presentation was 7.0 years (mean 6.7 years, SD = 5.4, range 2 months to 16 years). One-third of pathologically proven fibromuscular dysplasia cases presented before their first birthday. The age distribution of the 27 cases is shown in Fig. 1 . Neurological concerns were the presenting concern in the majority of patients (70%). Most cases had confirmed stroke (82%); however, transient ischaemic attack was also common (37%) and was the only neurological event in five patients (19%). The most common clinical presentation was acute motor deficits or hemiplegia (65%) and seizures (33%). Stroke location was not consistently reported (17 cases), but a predilection for the anterior circulation (71%) and multifocal arterial infarction (44%) was suggested.
Cerebral parenchymal and vascular imaging was variable and changed over the decades of time studied. The most common parenchymal imaging was CT (57%) whereas only 30% received MRI.
Across all 81 patients, all but nine (11%) had at least one form of cerebrovascular imaging. A high proportion of cases received conventional cerebral angiography (74.1%) whereas 15% received craniocervical CT angiography and 9% underwent magnetic resonance angiography. Within the pathologically proven group, 20 of 27 had cerebrovascular imaging including 95% with conventional angiography. Of those with cerebrovascular imaging, only six (25%) reported string-of-beads or similar appearance on angiography. Of these six patients, five (83%) had unclassifiable pathology while the other was classified as intimal fibroplasia. In the remaining 13 patients with pathologically proven fibromuscular dysplasia and cerebral angiography, the majority (64%) had arterial abnormalities described as focal or segmental stenosis or occlusion. Most of these (7 of 9) had intimal fibroplasia pathology. The presence of aneurysms was described in an additional four patients, all with intimal fibroplasia and often described as 'saccular', although further details were not available. Moyamoya syndrome was formally diagnosed in nine (33%) pathologically proven fibromuscular dysplasia cases whereas three additional patients had distal internal carotid involvement without a diagnosis of moyamoya. Features of arterial dissection were not described in any case of pathologically proven fibromuscular dysplasia with angiography. Unfortunately, limited descriptive details and inconsistencies in terminology across publications limited the ability to assess other arteriopathy details.
Renal arteriopathy was confirmed in 15 pathologically proven patients with fibromuscular dysplasia (56%). Of the 16 cases for which laterality data were available, there was an even distribution of unilateral and bilateral involvement. All 15 patients with renal arteriopathy and two others without had documented hypertension. Six literature cases did not report blood pressures. Levels of renin and aldosterone were not consistently investigated or reported. In those for which measurements were completed (aldosterone: nine patients, renin: four patients), results were interpreted as abnormal in 88%. Before stroke or transient ischaemic attack, only one patient was on anti-hypertensive medications whereas post-stroke, anti-hypertensive treatment was reported in 14 (61%).
Investigations for systemic arteriopathy (autopsy or imaging in non-autopsy cases) beyond the craniocervical and renal arteries was completed and reported in 21 of 27 (78%) of pathologically proven fibromuscular dysplasia cases. Of these, 16 (76%) had documented systemic arteriopathy. Locations involved included aortic (50%), celiac/mesenteric (43%), coronary (43%), peripheral/limbs (21%), pulmonary (14%), splenic (14%), external carotid artery (8%) and hepatic/pancreatic (8%).
Investigations for additional stroke risk factors within the pathologically proven fibromuscular dysplasia group were limited. As defined above, comprehensive stroke evaluations were reported in nine cases (33%). Although data were limited, all evaluations for additional cardiac and prothrombotic disorders were unremarkable. Examinations for 'vasculitis' were also limited (33% of cases) and typically normal, the only exception being modest, transient elevations in the erythrocyte sedimentation rate in three cases.
Medical treatment was variable and documentation of chronic treatments was limited by differing follow-up intervals and reporting. The majority of patients received at least one medical therapy (24, 89%). Anti-inflammatory treatment with corticosteroids was reported in 30%. Details on rationale, dosing and duration could not be extracted from the data set. At least one anti-thrombotic treatment was received by 35%. These included both anti-platelet (acetyl salicylic acid, 22%) and anti-coagulant (low molecular weight heparin or warfarin, 13%) strategies. Surgical treatments were reported in 16 of the pathologically proven cases with fibromuscular dysplasia (59%) including renal angioplasty (15%), nephrectomy (30%) and cerebral revascularization procedures (4%).
Outcome data were available for 21 pathologically proven fibromuscular dysplasia cases (78%). Mean duration of follow-up was 42.8 months (3.6 years), with a range of 1 to 228 months. Extrapolating from the Paediatric Stoke Outcome Measure score, 10 cases (48%) had good outcome compared to 17 (52%) with poor outcome. A total of 12 deaths were reported (44%). Nine individuals incurred a stroke recurrence (all ischaemic) (43%). The mean interval to recurrence was 29 AE 22 months (range 1-60 months).
Pathological versus clinically suspected fibromuscular dysplasia
A comparison between pathologically proven and clinically suspected fibromuscular dysplasia is presented in dysplasia were more likely to be older and present with arterial ischaemic stroke and unilateral, monofocal arteriopathy with string-of-beads angiography. They were less likely to have haemorrhagic stroke, moyamoya disease or hypertension, stroke recurrence or poor outcome including death. A subanalysis of post-pubertal (n = 15) children showed no differences in gender distribution, renal artery stenosis, hypertension or other variables associated with typical adult fibromuscular dysplasia.
Haemorrhagic strokes
Thirteen children had haemorrhagic stroke (16%, 54% male, median age 5.7 years). No clinically suspected fibromuscular dysplasia (n = 31) had haemorrhagic stroke. Locations were predominantly subarachnoid (46%) or intraparenchymal (39%). Pathology was available on 10 of 13 with intimal fibroplasia in 80%. All had hypertension and 75% had renal arteriopathy. Moyamoya syndrome was present in only two (17%) haemorrhagic stroke cases. Of nine cases reporting systemic arteriopathy investigation, seven (78%) were positive with aorta most common (83%). Surgical intervention was performed in 8 of 13 (62%). Mortality was high (46%) but six of seven survivors had good Paediatric Stoke Outcome Measure outcomes at median follow-up of 31 months.
Discussion
We present the largest series to date combined with a systematic literature review to explore the association of childhood stroke with fibromuscular dysplasia. Although such data limit conclusions, several novel, clinically relevant findings are identified that should improve awareness and advance research. A primary finding was the clear differences between pathological and clinically suspected fibromuscular dysplasia. We suggest that accurately labelling paediatric stroke patients as 'fibromuscular dysplasia' based purely on intracranial angiographic features, renal arteriopathy or other clinical grounds is not possible given current knowledge. Until better biomarkers of fibromuscular dysplasia are identified, pathological confirmation remains the only means by which fibromuscular dysplasia can be confirmed. Speculation on alternative aetiologies accounting for the many 'clinically suspected' fibromuscular dysplasia is facilitated by recent advances in childhood cerebral arteriopathies (Amlie-Lefond et al., 2009; Ganesan et al., 2011) . Transient cerebral arteriopathy (Chabrier et al., 1998; Sebire 2006 ) is a characterized arteriopathy syndrome accounting for a high proportion of arterial ischaemic stroke in school-aged children. Common features include arterial ischaemic stroke presentations with unilateral stenosing disease of the distal internal carotid, middle and anterior cerebral arteries. Angiography is distinctive, featuring arterial abnormalities very similar to string-of-beads with alternating areas of stenosis and dilatation. This syndrome is usually monophasic, resolving over months without associated renal or systemic arterial disease, and low mortality (Braun et al., 2009 ). The pathophysiology is unknown and may relate to intracranial dissection though inflammatory mechanisms have also been suggested. Terminology for this syndrome has varied, including transient cerebral arteriopathy (Chabrier et al., 1998; Sebire, 2006) , large-vessel childhood (Askalan et al., 1999) .
We suggest that a high proportion of our 'clinically suspected fibromuscular dysplasia' may in fact represent this disease. The differences we found supporting this include such children being of similar age, normal blood pressure, isolated unilateral arteriopathy, string-of-beads angiography, no occurrences of haemorrhagic stroke and better outcomes. That string-of-beads angiography is only recently well described in transient cerebral arteriopathy (Chabrier et al., 1998; Braun et al., 2009 ) and related syndromes (Fullerton et al., 2007; Elbers and Benseler, 2008; Bernard et al., 2012) would explain the tendency to historically consider a fibromuscular dysplasia diagnosis in such children. Our results suggest that fibromuscular dysplasia cannot be accurately diagnosed on such angiographic or other clinical factors and alternative aetiologies such as transient cerebral arteriopathy and intracranial dissection must be considered.
Intimal fibroplasia characterized most pathologically proven cases of fibromuscular dysplasia with childhood stroke. This provides important evidence that paediatric fibromuscular dysplasia differs from adult fibromuscular dysplasia where this pathological subtype is rare and not typically associated with stroke (Harrison and McCormack, 1971; Slovut and Olin, 2004; Touze et al., 2010) . Intimal involvement may predispose to arterial stroke through multiple mechanisms including luminal surface irregularities, turbulent flow or alterations in the normal endothelial anti-thrombotic properties. Such predilection for arterial ischaemic stroke suggests treatment with anti-platelet agents should be considered, both initially and for secondary stroke prevention in keeping with current Initial group comparisons (Chi-square categorical, ANOVA continuous) are followed by pairwise comparisons. Continuous variables are mean (SD). AIS = arterial ischaemic stroke; ECHO = echocardiogram; HS = haemorrhagic stroke; HTN = hypertension; RAS = renal artery stenosis; TIA = transient ischaemic attack; Tx = treatment; (*) inclusion requires evidence of unilateral AND intracranial arteriopathy.
guidelines (Paediatric Stroke Working Group, 2004; Monagle et al., 2008; Roach et al., 2008) However, only 22% of children in the pathologically proven group were treated with anti-platelet therapy. In addition, the disruption of the internal elastic lamina typical of intimal fibroplasia may reflect impaired vessel wall integrity, potentially predisposing to dissection, aneurysm formation, and haemorrhagic stroke. The combined risk of ischaemic and haemorrhagic stroke complicates approaches and estimates of risk:benefit of anti-thrombotic therapy. However, intimal fibroplasia and similar pathologies are well described in moyamoya (Scott and Smith, 2009 ) (see below) where anti-platelet treatments appear safe with a greater risk of ischaemic versus haemorrhagic stroke. Our data also suggest a significant risk of ischaemic stroke recurrence (36% within average 4 years follow-up), higher than that reported for adult fibromuscular dysplasia rates (Touze et al., 2010) , further supporting the need for secondary prevention. The relationship between fibromuscular dysplasia, stroke and moyamoya is complex and our data provide only one view-point. Dedicated case series of moyamoya were deliberately excluded. However, our criteria associating stroke with renal arteriopathy was expected to include some moyamoya because renal arteriopathy is present in 5-8% of moyamoya cases (Choi et al., 1997; Yamada et al., 2000; Togao et al., 2004) . Comparing our results with childhood moyamoya series is complicated by inconsistencies in terminology and a paucity of quality histopathological studies. Some pathological features reported in our fibromuscular dysplasia population have been described in moyamoya including abnormalities of the intima and internal elastic lamina (Fukui et al., 2000; Reid et al., 2010) . However, the largest moyamoya pathological series describes intimal hyperplasia, often with medial smooth muscle cell proliferation rather than the intimal fibroplasia that predominated in our cases with fibromuscular dysplasia (Takagi et al., 2007) . Distinctions between intimal hyperplasia and intimal fibroplasia are not well defined (Harrison and McCormack, 1971) , likely further clouding understanding of potential relationships between moyamoya and fibromuscular dysplasia. Current evidence supports that moyamoya is only a syndrome, associated with multiple diseases, only a small proportion of which are defined (Scott and Smith, 2009) . Perhaps the commonalities identified here can advance the consideration of childhood fibromuscular dysplasia as another underlying mechanism of childhood moyamoya.
Our study supports the importance of cerebrovascular imaging in childhood stroke. Most children with pathologically proven fibromuscular dysplasia did not have string-of-beads angiography and only one case with intimal fibroplasia did. In fact, most had much less specific arterial changes described as focal or segmental stenosis or occlusion. This is consistent with adult fibromuscular dysplasia classifications linking pathological subtypes with angiographic appearances (Stanley et al., 1975; Osborn and Anderson, 1977; Slovut and Olin, 2004) . In contrast, many clinical diagnoses of fibromuscular dysplasia appeared to rely on string-of-beads angiography. This suggests that fibromuscular dysplasia may be both under and over-diagnosed in children with stroke. We suggest that best available systemic angiography should be considered in all unexplained cases of childhood stroke with evidence of arteriopathy and that renal and systemic arteries be included when possible. Conventional cerebral angiography is established as safe in children (Burger et al., 2006; Wolfe et al., 2009) and may offer the most sensitive diagnostic information, but lack of availability at some paediatric centres suggests magnetic resonance or CT angiography are reasonable alternatives. Furthermore, serial vascular imaging is also likely required to best follow disease activity over time, possibly aiding in the differentiation of fibromuscular dysplasia from other forms of arteriopathy. However, absolute diagnosis of fibromuscular dysplasia does not appear achievable by even the best arterial imaging and should be reserved for pathologically confirmed cases only.
Although most cases of arteriopathy in children appear to be acquired, is it possible that stroke related to paediatric fibromuscular dysplasia represents a congenital arteriopathy? Several findings in our study support this possibility. First, a disproportionately high number of children with pathologically proven fibromuscular dysplasia presented in the first year of life. Second, widespread systemic arteriopathy was common in the pathologically proven group. Finally, outcomes overall were much worse in the pathologically proven group. Although some of this last finding could represent a selection bias as pathology was often obtained post-mortem, another consideration is a greater extent of multisystem arterial disease. In addition, some of the cases presenting in early infancy had evidence of pre-or perinatal brain injury (see Fig. 1 ). While family histories were unremarkable, consideration of congenital and/or genetic origins to childhood onset fibromuscular dysplasia arteriopathy should be considered.
As expected, investigational approaches were heterogeneous. However, some observations may assist clinicians in evaluating such patients. Hypertension is rarely associated with childhood stroke (Kirkham et al., 2000) and our results suggest its presence should prompt consideration of renal arteriopathy and possible fibromuscular dysplasia. A thorough evaluation should probably include blood pressure monitoring, screening for end-organ damage, renal ultrasound with Doppler, and measurements of renin and aldosterone. Essentially defined by the co-occurrence of renal arteriopathy and stroke without pathological or clinical suspicion of fibromuscular dysplasia, Group C (Table 2 ) represents a population of interest. Though biased by our inclusion criteria, the much greater similarities between Groups C and A shown in Table 2 suggest the possibility that a significant proportion of such children may in fact have fibromuscular dysplasia. Arterial imaging, both craniocervical and systemic, should leverage modern, non-invasive methods such as magnetic resonance angiography as best possible though conventional angiography may be required. A thorough stroke evaluation is likely still warranted in cases of suspected fibromuscular dysplasia including cardiac and thrombophilia evaluations and screening for vasculitidies though the yield of such appears to be low (Elbers and Benseler, 2008) .
The main limitations of this work are the combination of incomplete multisource registry and literature data spanning decades. However, recently published data from the larger US adult fibromuscular dysplasia registry (Olin et al., 2012) carries similar limitations, including subjective, imaging-based diagnostic criteria and virtually no pathological correlations. Extraction of all data elements of interest was not possible and evaluations reflected technological advancements including low rates of MRI. Major areas to improve in future studies include centralized, blinded neuroimaging and neuropathology review. Our choice to compare pathologically-confirmed fibromuscular dysplasia to the other two groups also creates limitations, including selection biases influencing group assignment. Foremost among these are the conditions facilitating the availability of pathological tissue such as nephrectomy or post-mortem examination. These limitations were the main reason why the primary analysis was limited to a descriptive examination of the pathologically proven group. However, the resulting description of pathologically confirmed fibromuscular dysplasia represents an important first step in elucidating the role of such arteriopathy in childhood stroke.
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